Internet-Based Interventions for MDD

Depression Clinical Trial

Official title:

Effectiveness of Internet-Based Interventions for Treatment Compliance and Outcomes of Major Depressive Disorder

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04684277
• Other study ID #: SF2020-2-4113
• Status: Recruiting
• Phase: N/A
• Start date: September 1, 2021
• Est. completion date: June 30, 2023

Study information

• Verified date: September 2021
• Source: Peking University
• Contact: Yunai Su, MD
• Phone: 8610-62352880
• Email: suyunai[@]163.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The acute and remission depression patients of 18-65 years old were recruited. At the time of enrollment, the demographic, symptomatic, neuropsychological and medication adherence data was collected. After the completion of the baseline assessment and examination, the patients were given antidepressant treatment or antidepressant treatment combined with Internet-based interventions. Clinical evaluation was performed at 1, 3 months (acute patients) and 6, 12 months (remission patients) after treatment, including the medication adherence, therapeutic efficacy, recurrence rate and functional rehabilitation. Through above work, this research is expected to provide clinicians with a set of Internet generalized technologies to improve the compliance and clinical outcomes of patients with depression, and to provide patients with treatment and management of the entire disease cycle.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 440
• Est. completion date: June 30, 2023
• Est. primary completion date: December 31, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• age 18-65 years old, acute (HAMD17 > 17) and remission (HAMD17 < 8) depression

Exclusion Criteria:

• other mental illnesses, serious somatic illnesses

Related Conditions & MeSH terms

• Depression
• Medication Adherence

Intervention

Drug:
• antidepressant treatment
depression recieve antidepressant treatment

Other:
• antidepressant treatment combined with Internet-based interventions
depression recieve antidepressant treatment combined with Internet-based interventions

Locations

Country	Name	City	State
China	Yunai Su	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Peking University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HAMD17 reduction ratio	The difference of HAMD17 reduction ratio between the two groups was compared	3 months
Primary	recurrence rate	The difference of recurrence rate between the two groups was compared	12 months